PowerPoint Presentation - ASPHO · ASPHO

Skip to main content

Menu Journal My Account Contact Join/Renew

Login

Meetings & Events
Knowledge Center
Career Development
Membership
About
2017 Annual Meeting Session Recordings
2018 Annual Meeting Session Recordings
George R. Buchanan Lectureship Award Presentation
Cancer Predispositions in Clinical Practice
Evidence and Equipoise in Pediatric Thrombosis - Updates from Randomized Controlled Trials
Playing on Our Strengths - Developing Interprofessional Teams in Pediatric Hematology-Oncology
Providing Optimal Pediatric Palliative Care: Overcoming the Barriers
When in Quebec, Do What the Quebecers Do (Part Deux) - It's All About Platelets!
Allogeneic Hematopoietic Stem Cell Transplantation (SCT) for Pediatric Patients with ALL in the era of Tyrosine Kinase Inhibitors, Novel Immunotherapies and 'MRD Status'
Award Presentations
Hemophilic Arthropathy, More Than Meets the Eye: Advances in Early Disease Detection from Clinical Tools to Musculoskeletal Imaging
ZFNs, CrispR/Cas9 and TALENS- Oh My!
Collaboration in the Treatment of Liver Tumors
Leukemia
Solid Tumors/Lymphoma
Hematology I
Beyond Antibodies and CAR T Cells: Challenges and Opportunities in Manipulating the Pediatric Cancer Immunome
Blood Clots in Sick Kids: A critical mini-review of venous thrombo-embolism in selected high-risk pediatric populations
It's not just about Diversity: Improving the Outcomes for All by Moving toward Equity
Children's Oncology Group (COG)
Outcomes Research
Social Media: The Good, The Bad, and Beyond
Sickle Cell Disease in the AYA population: Management Challenges for the Pediatric Hematologist
Molecularly Defined Rare Pediatric Sarcomas: An Update for the General Oncologist
Mechanisms of Tumor Microenvironment Immune Mediated Resistance and Methods of Therapeutic Circumvention
Behind the Scenes at Pediatric Blood & Cancer: Everything You Always Wanted to Know About Getting Published
New Insights in Inherited Hematologic Diseases
Changing Workforce of Pediatric Hematology/Oncology
New Diagnostic and Therapeutic Approaches of Opportunistic (Viral/Fungal) Infections in the Pediatric Cancer Patient
New Mutations and Targeted Therapies in Langerhans Cell Histiocytosis
Physician, Sustain Thyself: Building Resilience to Prevent Burnout
Practicing Precision in Pediatric Oncology: Three Perspectives
What's Happening in DC? A Look at ASPHO Advocacy Efforts
Critical Care of the Immunocompromised Pediatric Hematology/Oncology Patient
Brain Tumors
Hematology II
Sponsor, Exhibit, and Advertise
Ward Testing OSE
2018 Session | George R. Buchanan Lectureship Award Presentation
2018 Session | Plenary Paper Session 2001-2002
2018 Session | St. Baldrick's Foundation Robert J. Arceci Innovation Award Announcement
2018 Session | Plenary Session—Health Care in the Current Political Climate: Stormy Days Ahead?
2018 Session | Pediatric Ependymoma: The Science Driving Patient Care
2018 Session | Iron: Let's Get Pumped
2018 Session | Extracellular Vesicle Trafficking—Biology and Translational Impact in Hematology and Cancer
2018 Session | Relapsed, Refractory, Metastatic Bone Sarcomas: New Insights on Pathogenesis, Prognosis and Treatment
2018 Session | Alpha Thalassemia—A Growing Public Health Disease with Changing Landscape of In-Utero and Post-Natal Therapy
2018 Session | Decision Making in Benign Hematology: Living in a World Without Randomized Trials
2018 Session | Northwestern Mutual Award for Excellence in Childhood Cancer Survivorship
2018 Session | Early Career Travel Stipend Awards
2018 Session | Young Investigator Award Presentations
2018 Session | Management of Extracranial Germ Cell Tumors in Adolescent and Young Adult Population
2018 Session | Challenging Hematologic Complications Post–Stem Cell Transplantation and Beyond
2018 Session | Advanced Symptom Management and End-of-Life Care: Multidisciplinary Primary Palliative Care for Pediatric Hematologists/Oncologists
2018 Session | Paper Session - Solid Tumor
2018 Session | Paper Session - Hematology
2018 Session | Vascular Anomalies: The Great Mimickers
2018 Session | Addressing Sexual Health in Adolescent and Young Adult Patients: What You Should Know as a Pediatric Hematology/Oncology Care Provider
2018 Session | Navigating Intravascular Bottlenecks: A Critical Mini-Review of Pediatric Venous Thromboembolism in the Setting of an Anatomical Thrombophilia
2018 Session | Paper Session - Children's Oncology Group (COG)
2018 Session | Paper Session - Hematology Science
2018 Session | Can Late Effects be Prevented in Pediatric Oncology?
2018 Session | Clash of the Titans: Debates on Best Management of Patients with Bleeding Disorders
2018 Session | Providing Effective Feedback: The Currency of Conflict Resolution
2018 Session | Recent Advances and New Approaches to Rare Hematological Malignancies
2018 Session | Primary and Secondary Stroke Prevention in Sickle Cell Disease: The Debate
2018 Session | Combating an Unmet Need: Psychosocial Health
2018 Session | Renal Tumors Beyond Wilms
2018 Session | Pediatric and Neonatal Transfusion Medicine
2018 Session | Mobile Applications in Clinical Practice
2018 Session | Presidential Symposium—Partnering with Patients and Families to Improve Research and Clinical Decision-making
2018 Session | Review of Rare Pediatric Head and Neck Tumors for the General Oncologist
2018 Session | Emerging Therapies in Hemophilia
2018 Session | How Should You Treat That Bug? A Debate About Antimicrobial Management in Fever and Neutropenia
2018 Session | Paper Session with Luminary Investigator - Leukemia
2018 Session | Paper Session with Luminary Investigator - Hematology
2018 Session | Frank A. Oski Memorial Lectureship Award Presentation
December 2018 eNews
2019 Session | Splenectomy - The Great Debate
2019 Session | DICER1: Updates on Biology and Clinical Management
2019 Session | Burnout in Pediatric Hematology/Oncology: Moving from Discussion to Action
2019 Session | Diagnostic and Management Conundrums Surrounding Women with Heavy Menstrual Bleeding and Underlying Bleeding Disorders
2019 Session | All That Glitters is Not Gold – How We Differentiate Primary HLH from Fake News
Models for International Pediatric Oncology Outreach
2019 Session | Navigating Genetic Testing in the Pediatric Hematology Setting
2019 Session | Radiation Therapy for Pediatric Cancer Patients: Updates and New Modalities
2019 Session | The Microbiome: What Is It and Why Do We Care?
2019 Session | Brain Attack: Therapeutic Advances in Neonatal and Childhood Stroke
2019 Session | Advances in Pediatric AML
2019 Session | Improving Medication Adherence for Adolescents and Young Adults: Is Technology the Answer?
2019 Session | Metabolism in Pediatric Hematology/Oncology - Presidential Symposium
2019 Session | Too Much of a Good Thing – Myeloproliferation in Children
2019 Session | Multiple Bony Lytic Lesions, but Not Langerhans Cell Histiocytosis (LCH) – Now What?
2019 Session | Savior Siblings: Medical, Ethical, and Psychosocial Considerations in using Preimplantation Genetic Diagnosis (PGD) to Ensure a Matched Sibling Donor for Hematopoietic Stem Cell Transplantation (HSCT)
2019 Session | George R. Buchanan Lectureship Award Presentation
2019 Session | 2019 St. Baldrick’s Foundation Robert J. Arceci Innovation Award Announcement and Past Recipient Presentation
2019 Session | Northwestern Mutual Award for Excellence in Childhood Cancer Survivorship Announcement and Frank A. Oski Memorial Lectureship Award Presentation
2019 Session | New Paradigms for Severe Aplastic Anemia: Genetic Screening, Eltrombopag, and Up Front Unrelated Donor BMT
2019 Session | Not Too Young for That Cancer: Adolescent and Young Adult Carcinomas
2019 Session | Transforming the Treatment of Chronic Pain
2019 Session | Putting an End to End Organ Damage in Sickle Cell Disease
2019 Session | Defining Pediatric MDS: A Morphologic or Molecular Diagnosis?
2019 Session | The Power of One: Present Challenges in Treating Rare Diseases
2019 Session | Hematological Manifestations of Immune Deficiencies and Dysregulatory Disorders: When should you look harder for underlying causes of Autoimmune Cytopenias?
2019 Session | Oncofertility Programs: More Than Just Sperm Banking
2019 Session | The (Financial) Cost of a "Cure"
2019 Session | (2001) Potential Utility of MRD to Identify Relapse in pALL Patients Treated with Tisagenlecleucel
2019 Session | (2002) Lentiglobin Gene Therapy in Transfusion-Dependent Β-Thalassemia Patients with Non-β0/β0 Genotypes
2019 Session | (2003) Mechanisms of Resistance to the Type II JAK2 Inhibitor CHZ868 in B-Cell Acute Lymphoblastic Leukemia
2019 Session | (2004) Discovering Noncoding Genetic Elements that Regulate Globin Synthesis
2019 Session | (2005) Emapalumab in Pediatric Patients with Primary Hemophagocytic Lymphohistiocytosis: Safety & Efficacy
2019 Session | (2006) Modeling IKZF1 Lesions in B-cell Acute Lymphoblastic Leukemia Reveals Potential Therapeutic Targets
2019 Session | (2007) Prognostic Determinants in Childhood T-cell Acute Lymphoblastic leukemia: Results of DFCI 05001
2019 Session | (2008) Gap Junction Interference increases Apoptosis in ALL cells and augments effects of Antimetabolites
2019 Session | (2009) Hydroxyurea Lowers Tricuspid Regurgitant Jet Velocity in Children with Sickle Cell Anemia
2019 Session | (2010) Novel Next-Generation Sequence based Assay for Non-Invasive Prenatal Testing of Sickle Cell Disease
2019 Session | (2011) Gabapentin for Pain in Sickle Cell Disease: Results of a Randomized Phase II Clinical Trial
2019 Session | (2012) Quality of Life is the most important Indication for Second-Line ITP Treatment in Children
2019 Session | (2013) BCL2-Inhibitor Response in Neuroblastoma: Biomarkers and Therapy Resistance
2019 Session | (2014) The Clinical Application of Molecular Testing in Pediatric Solid Tumors: An Institutional Experience
2019 Session | (2015) Enhancing Tumor Directed T Cells with an Interleukin-7 Signal Modulator
2019 Session | (2016) Epigenome Screening Identifies Transcriptional Elongation as Therapeutic Vulnerability in DIPG
2019 Session | (2017) Levofloxacin Prophylaxis
2019 Session | (2018) Renal Tumors: Future Roadmap
2019 Session | (2019) Soft Tissue Sarcoma
2019 Session | (2020) Realizing Effectiveness across Continents with Hydroxyurea (REACH): A Prospective Multi-National Trial of Hydroxyurea for Sickle Cell Anemia in Sub-Saharan Africa
2019 Session | (2021) Leucine for the Treatment of Transfusion Dependence in Patients with Diamond Blackfan Anemia
2019 Session | (2022) A Phase 1/2 Trial of Investigational Spk-8011 in Hemophilia a Demonstrates Durable Expression and Prevention of Bleeds
2019 Session | (2023) Peripherally Inserted Central Catheters (PICCs), the Leading Cause of Central Venous Catheter Associated Thrombosis in Children
2019 Session | The Role of Survivorship Research in Advancing Childhood Cancer Care and Quality of Survival
2019 Session | (2024) Septic Shock (SS) Incidence in National ALL & AML Cohorts using Administrative & Clinical Trial Data
2019 Session | (2025) Nelarabine Abrogates Relapse Rates in CNS-3 T-ALL: A Report from Children’s Oncology Group AALL0434
2019 Session | (2026) Current Cancer Survivorship Practices: A Report from the Children’s Oncology Group (COG)
2019 Session | (2027) Intra-Arterial Chemotherapy for Retinoblastoma: A 7-year Single Institution Experience
2019 Session | Advancing Discovery in Hematology: Bench to Bedside? No. Bedside to Bench to Bedside...
2019 Session | (2028) The Shwachman Diamond Syndrome Registry: Hematologic Complications
2019 Session | (2029) Characteristics and Outcomes of Unprovoked Venous Thromboembolism in the Pediatric Population
2019 Session | (2030) Third Party VST are an effective Therapy for the Treatment of BK-Virus Reactivation after Transplant
2019 Session | (2031) Inhibition of Nemo-Like Kinase improves Erythropoiesis in Models of Diamond Blackfan Anemia
CI SIG Webinar
October 2021 eNews

Media
Categories

PowerPoint Presentation

Category

PowerPoint Presentation

Filter

Filter

Advertising, Exhibits, & Support | Career Center | Calendar | Contact Us

Terms of Use & Privacy Policy » © The American Society of Pediatric Hematology/Oncology^®